Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Rockwell Medical Inc’s stock clocked out at $2.01, down -1.47% from its previous closing price of $2.04. In other words, the price has decreased by -$1.47 from its previous closing price. On the day, 0.62 million shares were traded. RMTI stock price reached its highest trading level at $2.09 during the session, while it also had its lowest trading level at $1.98.
Ratios:
To gain a deeper understanding of RMTI’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.34. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.41. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 15 ’24 when RAVICH MARK H sold 19,991 shares for $2.32 per share. The transaction valued at 46,379 led to the insider holds 0 shares of the business.
RAVICH MARK H sold 10,000 shares of RMTI for $24,000 on Nov 15 ’24. The Director now owns 121,429 shares after completing the transaction at $2.40 per share. On Oct 01 ’24, another insider, Chole Timothy, who serves as the SVP, Chief Commercial Officer of the company, sold 1,001 shares for $3.69 each. As a result, the insider received 3,689 and left with 55,171 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 64960788 and an Enterprise Value of 90329520. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65 while its Price-to-Book (P/B) ratio in mrq is 2.23. Its current Enterprise Value per Revenue stands at 0.957 whereas that against EBITDA is -102.067.
Stock Price History:
Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -33.48%, while the 200-Day Moving Average is calculated to be -15.07%.
Shares Statistics:
It appears that RMTI traded 748.48K shares on average per day over the past three months and 597510 shares per day over the past ten days. A total of 32.32M shares are outstanding, with a floating share count of 28.45M. Insiders hold about 11.96% of the company’s shares, while institutions hold 29.27% stake in the company. Shares short for RMTI as of 1728950400 were 823372 with a Short Ratio of 1.32, compared to 1726185600 on 397531. Therefore, it implies a Short% of Shares Outstanding of 823372 and a Short% of Float of 2.6700001.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $23.65M. It ranges from a high estimate of $24.7M to a low estimate of $22.61M. As of the current estimate, Rockwell Medical Inc’s year-ago sales were $22.09MFor the next quarter, 2 analysts are estimating revenue of $19.12M. There is a high estimate of $20.2M for the next quarter, whereas the lowest estimate is $18.05M.
A total of 2 analysts have provided revenue estimates for RMTI’s current fiscal year. The highest revenue estimate was $101.52M, while the lowest revenue estimate was $99.43M, resulting in an average revenue estimate of $100.48M. In the same quarter a year ago, actual revenue was $83.61MBased on 2 analysts’ estimates, the company’s revenue will be $83.19M in the next fiscal year. The high estimate is $87.63M and the low estimate is $78.75M.
